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Abstract
The main question for staging is resectability, which is reliant on vascular, longitudinal, and metastatic spread. Today,
accurate staging of perihilar tumors is achieved by non-invasive diagnostic investigations. Direct cholangiography has been
the gold standard as a diagnostic procedure in recent decades. Endoscopic retrograde cholangiopancreaticography (ERCP)
often only shows the ducts below the obstruction, and visualization of an obstructed part of the biliary tree is often not
possible. Direct cholangiography reveals no information about local tumor extension, lymph nodes, or vascular
involvement. Because of the given limitations, potential complications (cholangitis, sepsis) associated with direct
cholangiography and reduction of the accuracy of subsequent cross-sectional imaging studies, these invasive techniques
should only be used in the case of palliative interventions. Endoscopic ultrasonography-guided fine-needle aspiration (EUS-
FNA) can be used to assess the nature of biliary strictures and to derive information about the extent of periductal disease
and the presence of lymph node metastases. In a study by Fritscher-Ravens, 44 patients with hilar strictures underwent
EUS-FNA. The overall diagnostic accuracy, sensitivity, specificity, positive and negative predictive values were 91% (95%
CI, 78.496.3%), 89% (95% CI, 73.396.8%), 100% (95% CI, 63.1100%), 100% (95% CI, 88.8100%), and 67% (95%
CI, 34.990%), respectively. The planned surgical approach was changed in 27 of 44 patients. In 1520% of
cholangiocarcinoma, patients with unremarkable abdominal imaging studies have metastatic lymph node involvement
according to EUS evaluation. Due to the risk of peritoneal seeding, however, EUS with FNA is not recommended in
patients still with a potential curative tumor.
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Introduction
The staging of cholangiocarcinoma (CCA) of endo-
scopic cholangiography, endoscopic ultrasonography,
intraductal ultrasound, brush cytology, biopsy, and
fine-needle aspiration (FNA) is discussed in this
article.
Diagnosis cholangiocarcinoma
If obstruction is secondary to a mass lesion, this lesion
must be staged with cross-sectional imaging techni-
ques before drainage procedures are performed [1]. If
stents are inserted before non-invasive diagnostic
investigations take place, the accuracy of subsequent
cross-sectional imaging is reduced.
Staging cholangiocarcinoma
The main question for staging is resectability, which is
reliant on vascular, longitudinal, and metastatic
spread. Today, accurate staging of perihilar tumors
is achieved ideally by non-invasive diagnostic investi-
gations, including ultrasonography, computed tomo-
graphy (CT) scan, and magnetic resonance
cholangiopancreatography (MRCP).
The most common staging system describes the
extent of tumor spread within the biliary system
according to the Bismuth classification [2], but a
main shortcoming of the Bismuth classification is lack
of information on any vascular involvement. It is
therefore not predictive of tumor resectability and
patient survival.
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Staging cholangiocarcinoma by endoscopic
techniques
Cholangiography
Direct cholangiography has been the gold standard
diagnostic procedure in recent decades. Endoscopic
retrograde cholangiopancreaticography (ERCP) often
only shows the ducts below the obstruction, and
visualization of an obstructed part of the biliary tree
is often not possible. In addition, opacification of
subsequently undrained liver segments puts the pa-
tient at risk for cholangitis. Percutaneous transhepatic
cholangiography (PTC) for patients with non-
communicating intrahepatic segments of the biliary
tree often requires several punctures of the individual
segments [3]. For obvious reasons, direct cholangio-
graphy reveals no information about local tumor
extension, lymph nodes, and vascular involvement.
Because of the given limitations, potential complica-
tions (cholangitis; sepsis) associated with direct cho-
langiography and reduction of the accuracy of
subsequent cross-sectional imaging studies, these
invasive techniques should only be used for palliative
interventions.
Combined multiphase CT and direct cholangiogra-
phy can be used for evaluation of the resectability of
HCCA. The combined interpretation of CT and
direct cholangiographic images resulted in an overall
accuracy of 74.5% for the prediction of resectability
[4].
A few minor studies [57] have compared MRCP
with ERCP in patients with hilar strictures. MRCP
and ERCP were both very effective in detecting the
presence of biliary obstructions (each 100%), but
MRCP was superior in investigating the anatomic
extent and the cause of the obstruction compared with
ERCP. MRCP was advantageous because it displayed
the biliary tree proximal to the obstruction.
In a prospective study, Coubie`re et al. [6] evaluated
the diagnostic value of MRC with direct cholangio-
graphy in patients referred for suspected CCA. Direct
cholangiography (percutaneous, n24 or endo-
scopic, n25) was performed within 7 days of the
MRC. The concordance between MRC and direct
cholangiography for the evaluation of surgical man-
agement was moderate with a kappa value of 0.55
(95% CI, 0.380.72), sensitivity of 84% (95% CI,
0.730.95), and specificity of 63% (95% CI, 0.49
0.77). The major limitation of this study was the
evaluation of MR cholangiograms only, and the MRI
potential of producing cross-sectional images of the
liver and vascular structures was not used.
Brushing, endoscopic biopsy, and fine-needle aspiration
Both PTC and ERCP techniques allow bile sampling,
brushing, and biopsies taken from the suspected
stricture for diagnosis. ERCP-guided brushing is a
very specific modality for diagnosis of carcinoma, but
it is not very sensitive. CCA is often desmoplastic,
resulting in acellular sampling. Biliary cytology is
positive for CCA in 30% of patients [8,9]. A
combination of brushing with endoscopic biopsies
increases the yield to 4070% [10,11]. In one study,
the sensitivity of routine brush cytology varied from
9% to 24% and specificity from 61% to 100%,
reflecting a high degree of interpathologist variation
[8]. Advanced cytology techniques for detection of
aneuploidy (digital image analysis) (DIA) and aneus-
omy (fluorescence in situ hybridization) (FISH)
increase sensitivity for the diagnosis of malignancy
to 3560% [12]. These sophisticated techniques are
not widely available.
Endoscopic ultrasonography
Endoscopic ultrasonography-guided FNA (EUS-
FNA) can be used for assessing the nature of biliary
strictures and for providing information on the extent
of periductal disease and the presence of lymph node
metastases.
A few prospective studies [1315] evaluated the role
of EUS-FNA in biliary strictures. In the study by
Fritscher-Ravens [13], 44 patients with hilar strictures
underwent EUS-FNA. The overall diagnostic accu-
racy, sensitivity, specificity, positive predictive value,
and negative predictive value were 91% (95% CI,
78.496.3%), 89% (95% CI, 73.396.8%), 100%
(95% CI, 63.1100%), 100% (95% CI, 88.8100%),
and 67% (95% CI, 34.990%), respectively. The
planned surgical approach was changed in 27 of 44
patients. In a study of 24 patients, EUS-FNA biopsy
of suspected CCA has shown a sensitivity, specificity,
positive predictive value, negative predictive value,
and accuracy of 77% (95% CI, 54–92%), 100% (95%
CI, 15100%), 100% (95% CI, 83–100%), 29%
(95% CI, 471%), and 79% (95% CI, 58–93%),
respectively [15]. The low negative predictive value
does not permit the reliable exclusion of malignancy
following a negative biopsy.
In 1520% of CCA, patients with unremarkable
abdominal imaging studies have metastatic lymph
node involvement according to EUS evaluation [16].
Endoscopic ultrasound (EUS) with FNA from either
the mass or the surrounding malignant-appearing
lymph nodes appears to have a higher sensitivity
than ERCP with brushing and biopsies [17]. The
advantage of EUS guided FNA is the avoidance of
contamination of the biliary tree as occurs with ERCP.
EUS with FNA, however, is not recommended in
patients still with a potential curative tumor due to the
risk of peritoneal seeding.
EUS data are only reported from tertiary referral
centres by specialists in ultrasonography. Lack of
experience with EUS-FNA of biliary tree lesions leads
to low sensitivities.
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Intraductal ultrasound
If no mass is identified on CT scan or MRI, a biliary
stricture is benign in 3049% of patients [1820]. In
these patients, intraductal ultrasound (IDUS) can be
used in combination with biliary brushing during
cholangiography. IDUS is performed with high-
frequency (1530 MHz), thin-caliber (2.02.4 mm)
probes. The depth of penetration is limited (2 cm),
but sufficient to provide an accurate image of the bile
duct wall, assess the depth of infiltration, and portal
vein and right hepatic artery invasion. IDUS has
limited value in assessing lymph node involvement
because of the limited depth of ultrasonic penetration.
EUS is superior to IDUS with respect to the detection
of lymph node metastases [21]. An important limita-
tion of IDUS is the inflammatory thickening induced
when prior stenting of the biliary stricture has been
performed [22]. The accuracy of IDUS in evaluation
of the extent of a tumor has been reported as 86%
[21,23]. When used in conjunction, IDUS increased
the accuracy of ERCP from 5860% to 8390% in
distinguishing between benign and malignant stricture
[19,20]. The accuracy of IDUS in assessing tumor
invasion to the right hepatic artery and portal vein is
92100% [21]. However, visualization of the left
hepatic and proper hepatic artery is poor (1418%)
due to anatomical features which cause ultrasound
attenuation.
Consensus statements
. Staging cross-sectional imaging techniques
should be performed before drainage procedures.
. Because of limitations and potential risks, direct
cholangiography (percutaneous or endoscopic
retrograde approach) should only be used for
preoperative and palliative drainage.
. Brush cytology has a low sensitivity and negative
predictive value and limits the ability to exclude
malignancy.
. IDUS can be considered if staging cross-
sectional imaging techniques are inconclusive.
References
[1] Khan SA, Davidson BR, Goldin R, et al. Guidelines for the
diagnosis and treatment of cholangiocarcinoma: consensus
document. Gut 2002;51 Suppl 6: vi19.
[2] Bismuth H, Castaing D, Traynor O. Resection or palliation:
priority of surgery in the treatment of hilar cancer. World J
Surg 1988;/12:/3947.
[3] Nimura Y, Kamiya J, Kondo S, et al. Aggressive preoperative
management and extended surgery for hilar cholangiocarci-
noma: Nagoya experience. J Hepatobil Pancreat Surg 2000;/7:/
15562.
[4] Lee HY, Kim SH, Lee JM, et al. Preoperative assessment of
resectability of hepatic hilar cholangiocarcinoma: combined
CTand cholangiography with revised criteria. Radiology 2006;/
239:/11321.
[5] Zidi SH, Prat F, Le Guen O, et al. Performance characteristics
of magnetic resonance cholangiography in the staging of
malignant hilar strictures. Gut 2000;/46:/1036.
[6] Coubie`re M, Pilleul F, Henry L, et al. Value of magnetic
resonance cholangiography in benign and malignant biliary
stenosis: comparative study with direct cholangiography.
J Comput Assist Tomogr 2003;/27:/31520.
[7] Vogl TJ, Schwarz WO, Heller M, et al. Staging of Klatskin
tumours (hilar cholangiocarcinomas): comparison of MR
cholangiography, MR imaging, and endoscopic retrograde
cholangiography. Eur Radiol 2006;/16:/231725.
[8] Harewood GC, Baron TH, Stadheim LM, et al. Prospective,
blinded assessment of factors influencing the accuracy of
biliary cytology interpretation. Am J Gastroenterol 2004;/99:/
14649.
[9] Selvaggi SM. Biliary brushing cytology. Cytopathology 2004;/
15:/749.
[10] Howell DA, Beveridge RP, Bosco J, et al. Endoscopic needle
aspiration biopsy at ERCP in the diagnosis of biliary strictures.
Gastrointest Endosc 1992;/38:/5315.
[11] Jailwala J, Fogel EL, Sherman S, et al. Triple-tissue sampling
at ERCP in malignant biliary obstruction. Gastrointest
Endosc 2000;/51:/38390.
[12] Moreno Luna LE, Kipp B, Halling KC, et al. Advanced
cytologic techniques for the detection of malignant pancrea-
tobiliary strictures. Gastroenterology 2006;/131:/106472.
[13] Fritscher-Ravens A, Broering DC, Knoefel WT, et al. EUS-
guided fine-needle aspiration of suspected hilar cholangiocar-
cinoma in potentially operable patients with negative brush
cytology. Am J Gastroenterol 2004;/99:/4551.
[14] Eloubeidi MA, Chen VK, Jhala NC, et al. Endoscopic
ultrasound-guided fine needle aspiration biopsy of suspected
cholangiocarcinoma. Clin Gastroenterol Hepatol 2004;/2:/209
13.
[15] DeWitt J, Misra VL, LeBlanc JK, et al. EUS-guided FNA of
proximal biliary strictures after negative ERCP brush cytology
results. Gastrointest Endosc 2006;/64:/32533.
[16] Gores GJ. Early detection and treatment of cholangiocarci-
noma. Liver Transpl 2000;/6:/S304.
[17] Fritscher-Ravens A, Broering DC, Sriram PV. EUS-guided
fine-needle aspiration cytodiagnosis of hilar cholangiocarci-
noma: a case series. Gastrointest Endosc 2000;/52:/53440.
[18] Farrell RJ, Jain AK, Wang H, et al. The combination of
stricture dilatation, endoscopic needle aspiration and biliary
brushing significantly improves the diagnostic yield of malig-
nant bile duct strictures. Gastrointest Endosc 2001;/54:/587
94.
[19] Domagk D, Wessling J, Reimer P, et al. Endoscopic retrograde
ultrasonography, and magnetic resonance cholangiography in
bile duct strictures: a prospective comparison of imaging
diagnostics with histopathological correlation. Am J Gastro-
enterol 2004;/99:/16849.
[20] Stavaropoulos S, Larghi A, Verna E, et al. Intraductal
ultrasound for the evaluation of patients with biliary strictures
and no abdominal mass on computed tomography. Endoscopy
2005;/37:/71521.
[21] Mentzel J, Poremba C, Dietl KH, et al. Preoperative diagnosis
of bile duct strictures  comparison of intraductal ultrasono-
graphy with conventional endosonography. Scand J Gastro-
enterol 2000;/35:/7782.
[22] Tamada K, Tomiyama T, Ischiyama M, et al. Influence of
biliary drainage catheter on bile duct wall thickness as
measured by intraductal ultrasonography. Gastrointest Endosc
1998;/47:/2833.
[23] Tamada K, Hagai H, Yasuda Y, et al. Transpapillary intra-
ductal US prior to biliary drainage in the assessment of
longitudinal spread of extrahepatic bile duct carcinoma.
Gastrointest Endosc 2001;/53:/3007.
112 E. A. J. Rauws et al.
